Target intelligence / Profile preview

SIPL protein pseudogene

Molecular classification
Other (Pseudogene)
01

Overview

The SIPL protein pseudogene (ENSG00000233877) is classified as a non-coding pseudogene, meaning it is a DNA sequence highly similar to a protein-coding gene but rendered non-functional by mutations or deletions preventing proper transcription or translation[1][2][4]. While pseudogenes in general were once considered "junk DNA," research indicates that some can be transcribed into non-coding RNAs and may regulate the expression of their parent or other genes at the RNA level[2][3][4]. However, there is no direct evidence that the SIPL protein pseudogene plays a functional or regulatory role, nor does it encode a therapeutic target or a protein. There are no known drug interactions, established mechanism of action, or clinical disease associations specific to this pseudogene. It is not used as a biomarker and has no notable safety concerns. Its main relevance is as part of genome annotation and studies on genome evolution and gene regulation[1][2][4][5].

Other names
SIPL protein (SIPL) pseudogene
02

Biological functions

Possible gene regulation (through RNA transcript), but no established protein function
03

Disease associations

Potential roles in regulation and disease are not established for this particular pseudogene; in general, pseudogenes have been implicated in cancer and genetic regulation, but no direct evidence exists for SIPL protein pseudogene

Beyond the preview

Go deeper on SIPL protein pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SIPL protein pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call